- 公司资讯
- finviz | 2022年04月29日 04:30Adaptimmune to Report Q1 2022 Financial Results and Business Updates on Monday, May 9, 2022
- finviz | 2022年04月26日 19:24New Strong Sell Stocks for April 26th
- finviz | 2022年04月22日 21:03New Strong Sell Stocks for April 22nd
- finviz | 2022年04月20日 03:43Why Adaptimmune Therapeutics, Agenus, and Sorrento Therapeutics Popped Today
- finviz | 2022年04月12日 04:40Why Adaptimmune Therapeutics Shares Dropped 14.7% on Monday
- finviz | 2022年04月09日 01:00Adaptimmune Presents MAGE-A4 Expression Data from its Screening Protocol at AACR Confirming Expression Across a Broad Range of Solid Tumors
- finviz | 2022年03月25日 19:18New Strong Sell Stocks for March 25th
- finviz | 2022年03月14日 23:31Tenet Healthcare (THC) Up 55% in a Year: Is More Upside Left?
- finviz | 2022年03月14日 20:00Adaptimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
- finviz | 2022年03月09日 04:14Gilead's (GILD) Trodelvy Late-Line Breast Cancer Study Meets Goal
- finviz | 2022年03月09日 00:36Adaptimmune to Report Q4 and Full Year 2021 Financial Results and Business Updates on Monday, March 14, 2022
- finviz | 2022年03月02日 23:22Epizyme (EPZM) Q4 Loss Wider Than Expected, Revenues Lag
- finviz | 2022年03月02日 23:16Axsome (AXSM) Posts Narrower-Than-Expected Q4 Loss
- finviz | 2022年03月02日 22:00After Plunging 19.1% in 4 Weeks, Here's Why the Trend Might Reverse for Adaptimmune Therapeutics PLC (ADAP)
- finviz | 2022年02月25日 02:49Clovis (CLVS) Q4 Loss Narrower than Expected, Revenues Lag
- finviz | 2022年02月18日 22:29Agios (AGIO) Gets FDA Nod for Rare Anemia Drug Mitapivat